TRIAMCINOLONE ACETONIDE

TRIAMCINOLONE ACETONIDE was reported 32022 times

TRIAMCINOLONE ACETONIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 155 0.5116
1 HEPATIC ENZYME 70 0.4698
2 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 139 0.4137
3 MASTITIS BACTERIAL 26 0.4062
4 HYPOCHOLESTEROLAEMIA 109 0.3088
5 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 203 0.3039
6 PSEUDOENDOPHTHALMITIS 27 0.2727
7 SWOLLEN JOINT COUNT 66 0.2640
8 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 27 0.2571
9 C-REACTIVE PROTEIN 238 0.2567
10 INFECTIVE SCLERITIS 23 0.2556
11 FACET JOINT SYNDROME 782 0.2400
12 ORBITAL INFECTION 21 0.2360
13 TENDER JOINT COUNT 19 0.2262
14 LUPUS VULGARIS 280 0.2222
15 BODY HEIGHT BELOW NORMAL 137 0.2131
16 PSEUDOMENINGOCELE 31 0.1975
17 NECROTISING SCLERITIS 28 0.1931
18 DEEP VEIN THROMBOSIS POSTOPERATIVE 383 0.1912
19 RHEUMATIC FEVER 799 0.1791
20 SWOLLEN JOINT COUNT INCREASED 557 0.1745
21 RETINITIS 298 0.1724
22 BONE DENSITY INCREASED 59 0.1479
23 NON-INFECTIOUS ENDOPHTHALMITIS 125 0.1472
24 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 304 0.1466
25 SHORT STATURE 38 0.1450
26 DISLOCATION OF VERTEBRA 320 0.1402
27 PERIPHERAL VENOUS DISEASE 572 0.1399
28 SERONEGATIVE ARTHRITIS 159 0.1387
29 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 76 0.1355
30 ANKLE ARTHROPLASTY 49 0.1350
31 JOINT DESTRUCTION 205 0.1317
32 RHEGMATOGENOUS RETINAL DETACHMENT 27 0.1292
33 DUODENAL ULCER PERFORATION 957 0.1286
34 RHEUMATOID FACTOR POSITIVE 727 0.1257
35 CONJUNCTIVAL ULCER 17 0.1232
36 X-RAY ABNORMAL 219 0.1223
37 CHORIORETINAL DISORDER 24 0.1218
38 HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION 43 0.1198
39 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 850 0.1185
40 EYE INFECTION TOXOPLASMAL 47 0.1184
41 FOLLICULITIS 1103 0.1051
42 GRIP STRENGTH 24 0.1048
43 BREAST CANCER STAGE III 676 0.1043
44 CENTRAL SEROUS CHORIORETINOPATHY 71 0.1040
45 INJECTION SITE ATROPHY 165 0.1002
46 MUSCLE INJURY 810 0.0977
47 C-REACTIVE PROTEIN ABNORMAL 627 0.0976
48 FEMALE GENITAL TRACT FISTULA 163 0.0954
49 HELICOBACTER INFECTION 972 0.0945
50 EYE ABSCESS 28 0.0918
51 LIP DRY 809 0.0890
52 HAND DEFORMITY 1136 0.0865
53 PEMPHIGUS 1065 0.0851
54 TOPICAL STEROID WITHDRAWAL REACTION 31 0.0797
55 BLEPHAROSPASM 497 0.0789
56 SYNOVITIS 1411 0.0782
57 ANTIBODY TEST POSITIVE 128 0.0771
58 JOINT RANGE OF MOTION DECREASED 1008 0.0751
59 WOUND INFECTION 809 0.0738
60 ONYCHOMADESIS 304 0.0724
61 NECROTISING RETINITIS 46 0.0719
62 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 463 0.0712
63 BONE EROSION 242 0.0684
64 MACULAR DEGENERATION 798 0.0668
65 PORPHYRIA ACUTE 95 0.0662
66 HYPERCHOLESTEROLAEMIA 629 0.0651
67 CHRONIC SINUSITIS 242 0.0644
68 RADICULOPATHY 165 0.0625
69 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 142 0.0616
70 ONYCHOMYCOSIS 260 0.0592
71 JUVENILE IDIOPATHIC ARTHRITIS 143 0.0584
72 BURSITIS 708 0.0583
73 OCULAR HYPERTENSION 113 0.0582
74 PERICARDITIS 967 0.0575
75 LIVE BIRTH 466 0.0556
76 PROCTITIS 156 0.0556
77 POLYARTHRITIS 290 0.0550
78 OBESITY 876 0.0549
79 ADRENAL SUPPRESSION 46 0.0546
80 GLOSSODYNIA 1197 0.0534
81 NAIL DISORDER 460 0.0525
82 SPINAL CORD INFARCTION 23 0.0522
83 IRRITABLE BOWEL SYNDROME 1087 0.0506
84 GRIP STRENGTH DECREASED 438 0.0497
85 CHOROIDITIS 18 0.0481
86 DRUG SPECIFIC ANTIBODY 64 0.0467
87 WOUND 1301 0.0465
88 FINGER DEFORMITY 212 0.0437
89 FIBROMYALGIA 1062 0.0436
90 RED BLOOD CELL SEDIMENTATION RATE INCREASED 451 0.0407
91 RETINAL ARTERY OCCLUSION 95 0.0376
92 DIABETIC RETINAL OEDEMA 19 0.0374
93 OVERLAP SYNDROME 26 0.0371
94 ADRENAL INSUFFICIENCY 443 0.0365
95 AUTOIMMUNE DISORDER 353 0.0362
96 CUSHING'S SYNDROME 25 0.0360
97 SYSTEMIC LUPUS ERYTHEMATOSUS 1270 0.0357
98 IMPAIRED HEALING 1147 0.0349
99 MATERNAL EXPOSURE TIMING UNSPECIFIED 131 0.0348
100 TYPE 2 DIABETES MELLITUS 1169 0.0347
101 SCIATICA 551 0.0345
102 SKIN HYPOPIGMENTATION 60 0.0339
103 HYPOPYON 28 0.0338
104 SOFT TISSUE SWELLING 19 0.0335
105 CHORIORETINOPATHY 47 0.0330
106 LIVER INJURY 808 0.0329
107 WHEELCHAIR USER 146 0.0328
108 PRODUCT LABEL CONFUSION 189 0.0324
109 EXOSTOSIS 296 0.0324
110 DRUG TOLERANCE DECREASED 90 0.0320
111 VITREOUS OPACITIES 27 0.0320
112 OPHTHALMIC HERPES SIMPLEX 18 0.0312
113 CYTOMEGALOVIRUS CHORIORETINITIS 61 0.0312
114 CATARACT SUBCAPSULAR 19 0.0311
115 SEBORRHOEIC KERATOSIS 45 0.0310
116 LUPUS-LIKE SYNDROME 277 0.0305
117 INFUSION SITE REACTION 90 0.0301
118 DRUG TOLERANCE 151 0.0298
119 ENDOPHTHALMITIS 175 0.0291
120 PSORIATIC ARTHROPATHY 1181 0.0291
121 RETINAL PIGMENT EPITHELIAL TEAR 20 0.0288
122 PULMONARY FIBROSIS 547 0.0285
123 FOOT DEFORMITY 313 0.0282
124 JOINT DISLOCATION 298 0.0282
125 RETINAL ISCHAEMIA 17 0.0278
126 WALKING AID USER 179 0.0271
127 BACK INJURY 293 0.0269
128 TASTE DISORDER 546 0.0269
129 GUTTATE PSORIASIS 22 0.0268
130 PRESCRIBED UNDERDOSE 525 0.0263
131 ATROPHY 50 0.0257
132 SKIN WEEPING 90 0.0252
133 LOWER LIMB FRACTURE 484 0.0252
134 CONTRAINDICATED PRODUCT ADMINISTERED 752 0.0248
135 STEROID WITHDRAWAL SYNDROME 25 0.0245
136 PRESCRIBED OVERDOSE 452 0.0233
137 C-REACTIVE PROTEIN INCREASED 843 0.0231
138 LIPOATROPHY 22 0.0231
139 SPONDYLITIS 84 0.0231
140 PRODUCT USED FOR UNKNOWN INDICATION 29 0.0230
141 PUSTULAR PSORIASIS 79 0.0230
142 NIGHT SWEATS 732 0.0227
143 SKIN ATROPHY 130 0.0226
144 SOFT TISSUE DISORDER 24 0.0216
145 INFUSION RELATED REACTION 1423 0.0214
146 THERAPEUTIC PRODUCT CROSS-REACTIVITY 19 0.0213
147 SECONDARY ADRENOCORTICAL INSUFFICIENCY 32 0.0212
148 GAIT INABILITY 708 0.0212
149 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 17 0.0207
150 COELIAC DISEASE 197 0.0201
151 OSTEOARTHRITIS 848 0.0200
152 WHEEZING 1167 0.0197
153 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 333 0.0196
154 NORMAL NEWBORN 106 0.0195
155 SKIN FISSURES 380 0.0194
156 INFLAMMATION 983 0.0190
157 BREAST CANCER STAGE II 157 0.0189
158 PRODUCT DELIVERY MECHANISM ISSUE 99 0.0184
159 INFUSION SITE RASH 25 0.0182
160 ARTHROPATHY 1005 0.0181
161 CYSTOID MACULAR OEDEMA 34 0.0180
162 STOMATITIS 1094 0.0180
163 LIVER FUNCTION TEST INCREASED 382 0.0178
164 LOWER RESPIRATORY TRACT INFECTION 803 0.0176
165 TELANGIECTASIA 17 0.0176
166 SCLERITIS 28 0.0175
167 THERAPEUTIC PRODUCT EFFECT DECREASED 783 0.0175
168 REBOUND ATOPIC DERMATITIS 35 0.0174
169 HIP ARTHROPLASTY 265 0.0173
170 VAGINAL DISCHARGE 174 0.0172
171 DERMATITIS ATOPIC 904 0.0171
172 INFUSION SITE DISCHARGE 30 0.0171
173 BLOOD CHOLESTEROL INCREASED 791 0.0170
174 RASH VESICULAR 82 0.0169
175 SPINAL FUSION SURGERY 68 0.0167
176 BLISTER 936 0.0166
177 ESSENTIAL HYPERTENSION 30 0.0164
178 SKIN HAEMORRHAGE 241 0.0162
179 XEROSIS 20 0.0162
180 RETINAL VASCULITIS 19 0.0160
181 MOBILITY DECREASED 1140 0.0159
182 PARAESTHESIA ORAL 227 0.0157
183 IMMUNODEFICIENCY 234 0.0157
184 EPILEPSY 468 0.0153
185 ALLERGY TO CHEMICALS 19 0.0152
186 NASAL PRURITUS 19 0.0152
187 ROAD TRAFFIC ACCIDENT 630 0.0150
188 ORAL CANDIDIASIS 198 0.0150
189 HEPATIC ENZYME INCREASED 1023 0.0150
190 EYELID SKIN DRYNESS 18 0.0148
191 LUNG DISORDER 727 0.0148
192 CUSHINGOID 47 0.0146
193 SLEEP DISORDER 1027 0.0145
194 MUSCULOSKELETAL PAIN 751 0.0143
195 EYELID PAIN 29 0.0143
196 THERAPY NON-RESPONDER 635 0.0141
197 B-LYMPHOCYTE COUNT DECREASED 19 0.0140
198 INTRAOCULAR PRESSURE INCREASED 178 0.0139
199 SEBORRHOEIC DERMATITIS 23 0.0139
200 ILL-DEFINED DISORDER 841 0.0138
201 HEPATIC CIRRHOSIS 259 0.0138
202 SWELLING 1285 0.0137
203 INJURY 963 0.0137
204 JOINT STIFFNESS 358 0.0136
205 ADVERSE REACTION 180 0.0136
206 RETINAL DEGENERATION 17 0.0131
207 SCRATCH 138 0.0131
208 ECZEMA 673 0.0128
209 EYE INJURY 39 0.0128
210 NASAL DISCOMFORT 101 0.0127
211 NASAL DRYNESS 78 0.0124
212 DRUG-INDUCED LIVER INJURY 389 0.0124
213 RHINALGIA 34 0.0124
214 RHEUMATOID ARTHRITIS 1391 0.0122
215 OEDEMA 663 0.0122
216 DEATH NEONATAL 17 0.0122
217 SKIN SWELLING 104 0.0120
218 FREQUENT BOWEL MOVEMENTS 321 0.0119
219 KNEE ARTHROPLASTY 248 0.0118
220 DRY MOUTH 952 0.0117
221 FOOT OPERATION 58 0.0117
222 GASTROENTERITIS VIRAL 210 0.0116
223 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 199 0.0116
224 DRUG INTOLERANCE 1106 0.0114
225 CEREBROSPINAL FLUID LEAKAGE 21 0.0114
226 LIVER DISORDER 502 0.0113
227 REBOUND ECZEMA 23 0.0112
228 INTENTIONAL PRODUCT USE ISSUE 984 0.0112
229 DISCOMFORT 685 0.0112
230 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 796 0.0112
231 JOINT SWELLING 1343 0.0111
232 NODULE 145 0.0111
233 NEURODERMATITIS 41 0.0110
234 ULCER HAEMORRHAGE 74 0.0109
235 POOR QUALITY PRODUCT ADMINISTERED 113 0.0107
236 DERMATITIS CONTACT 122 0.0107
237 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 28 0.0105
238 METAMORPHOPSIA 19 0.0103
239 VITRITIS 19 0.0103
240 DEVICE INFUSION ISSUE 25 0.0101
241 EAR INFECTION 264 0.0099
242 SKIN EXFOLIATION 834 0.0099
243 JOINT EFFUSION 68 0.0099
244 MACULAR OEDEMA 55 0.0098
245 TREATMENT FAILURE 813 0.0098
246 PNEUMONIA VIRAL 31 0.0097
247 VERTIGO POSITIONAL 17 0.0097
248 HYPOCALCAEMIA 181 0.0096
249 EYE INFLAMMATION 91 0.0095
250 MYOSITIS 85 0.0095
251 OSTEOPOROSIS 386 0.0094
252 INFUSION SITE ERYTHEMA 79 0.0094
253 EYELID MARGIN CRUSTING 27 0.0093
254 DELIRIUM 324 0.0093
255 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 446 0.0093
256 INJECTION SITE INDENTATION 20 0.0092
257 PUPILLARY REFLEX IMPAIRED 17 0.0092
258 MATERNAL EXPOSURE DURING PREGNANCY 818 0.0092
259 HYPOAESTHESIA 1361 0.0091
260 GENERAL PHYSICAL HEALTH DETERIORATION 1051 0.0091
261 INFUSION SITE SWELLING 57 0.0090
262 VITREOUS HAEMORRHAGE 25 0.0090
263 PARANASAL SINUS DISCOMFORT 34 0.0090
264 DISABILITY 176 0.0089
265 INFUSION SITE PAIN 114 0.0088
266 INFUSION SITE HAEMORRHAGE 29 0.0088
267 THERAPEUTIC RESPONSE DECREASED 533 0.0088
268 SINUSITIS 900 0.0088
269 MUSCULOSKELETAL STIFFNESS 753 0.0086
270 URTICARIA 1436 0.0086
271 INFUSION SITE PRURITUS 27 0.0085
272 BLOOD IRON INCREASED 16 0.0085
273 DRY SKIN 1135 0.0085
274 BLOOD PRESSURE SYSTOLIC ABNORMAL 21 0.0085
275 HEPATITIS 217 0.0085
276 PROCEDURAL PAIN 235 0.0085
277 GASTROOESOPHAGEAL REFLUX DISEASE 680 0.0084
278 RETINAL HAEMORRHAGE 60 0.0084
279 EXPOSURE DURING PREGNANCY 521 0.0084
280 DERMATITIS PSORIASIFORM 17 0.0083
281 DYSPEPSIA 811 0.0082
282 PAPULE 58 0.0082
283 ROSACEA 38 0.0081
284 GENERAL SYMPTOM 61 0.0081
285 EAR PAIN 157 0.0081
286 THERAPY PARTIAL RESPONDER 125 0.0080
287 PERIPHERAL SWELLING 1233 0.0080
288 PERIORBITAL SWELLING 45 0.0080
289 UPPER RESPIRATORY TRACT INFECTION 361 0.0078
290 CONGENITAL ANOMALY 60 0.0077
291 SUSPECTED OFF LABEL USE 35 0.0077
292 INFECTION 1119 0.0077
293 SINUS PAIN 18 0.0077
294 PSORIASIS 1008 0.0077
295 TYPE I HYPERSENSITIVITY 27 0.0077
296 CALCINOSIS 17 0.0076
297 CHRONIC GASTRITIS 17 0.0075
298 RETINAL DETACHMENT 69 0.0075
299 ARTHRITIS 588 0.0075
300 SKIN EROSION 24 0.0074
301 PREGNANCY 148 0.0074
302 PRURITUS 2833 0.0074
303 MIGRAINE 703 0.0074
304 GASTROINTESTINAL DISORDER 659 0.0073
305 PRODUCT USE IN UNAPPROVED INDICATION 1808 0.0073
306 POSTMENOPAUSAL HAEMORRHAGE 19 0.0073
307 EYE PRURITUS 243 0.0072
308 SEASONAL ALLERGY 102 0.0072
309 WEIGHT FLUCTUATION 75 0.0072
310 CONJUNCTIVAL HAEMORRHAGE 27 0.0071
311 PRODUCT CONTAMINATION 25 0.0070
312 EAR CONGESTION 19 0.0070
313 SKIN PLAQUE 58 0.0069
314 HYPERSENSITIVITY 1275 0.0069
315 NECK PAIN 382 0.0068
316 ERYTHEMA OF EYELID 37 0.0068
317 INJECTION SITE ABSCESS 17 0.0068
318 CONTUSION 653 0.0068
319 SKIN HYPERTROPHY 19 0.0068
320 ABDOMINAL DISCOMFORT 1133 0.0067
321 RECTAL HAEMORRHAGE 290 0.0067
322 CONJUNCTIVITIS 125 0.0067
323 BLEPHARITIS 27 0.0067
324 BACK DISORDER 109 0.0067
325 PRODUCT PHYSICAL CONSISTENCY ISSUE 37 0.0067
326 SEPTIC SHOCK 288 0.0066
327 SKIN MASS 44 0.0066
328 NASOPHARYNGITIS 1213 0.0066
329 UPPER-AIRWAY COUGH SYNDROME 54 0.0065
330 TENOSYNOVITIS 18 0.0065
331 MACULE 18 0.0065
332 INJECTION SITE DISCOLOURATION 81 0.0065
333 EYE DISCHARGE 67 0.0064
334 DERMATITIS 134 0.0064
335 HYPERTENSION 1350 0.0064
336 SKIN ABRASION 30 0.0063
337 HYPERKERATOSIS 35 0.0063
338 DERMATOMYOSITIS 16 0.0063
339 SKIN DISCOMFORT 17 0.0063
340 THERAPEUTIC RESPONSE SHORTENED 209 0.0063
341 WEIGHT INCREASED 1410 0.0063
342 MEMORY IMPAIRMENT 864 0.0063
343 UNDERDOSE 456 0.0062
344 HORDEOLUM 27 0.0062
345 INCORRECT PRODUCT STORAGE 82 0.0062
346 CONFUSIONAL STATE 998 0.0062
347 MELANOCYTIC NAEVUS 27 0.0062
348 PIGMENTATION DISORDER 38 0.0061
349 TENDERNESS 64 0.0061
350 MUSCULAR WEAKNESS 697 0.0061
351 RASH 2667 0.0061
352 EYELIDS PRURITUS 19 0.0061
353 DEAFNESS NEUROSENSORY 20 0.0061
354 THERAPEUTIC RESPONSE DELAYED 17 0.0061
355 RHINITIS ALLERGIC 27 0.0061
356 CONDITION AGGRAVATED 1822 0.0060
357 MUSCLE SPASTICITY 73 0.0059
358 MACULOPATHY 21 0.0059
359 COLITIS ULCERATIVE 264 0.0059
360 ALOPECIA 1157 0.0059
361 DRY EYE 288 0.0058
362 SEDATION 151 0.0058
363 OCULAR HYPERAEMIA 273 0.0057
364 NASAL CONGESTION 337 0.0057
365 PARAESTHESIA 900 0.0057
366 EYE PAIN 320 0.0057
367 PRODUCT USE ISSUE 1057 0.0056
368 BONE DENSITY DECREASED 176 0.0056
369 ARTHRITIS INFECTIVE 26 0.0056
370 LACRIMATION INCREASED 169 0.0056
371 SCAB 63 0.0055
372 VASCULAR DEVICE INFECTION 25 0.0055
373 GLAUCOMA 105 0.0054
374 HYPOKALAEMIA 251 0.0054
375 AMNESIA 352 0.0054
376 EYE INFECTION 61 0.0054
377 VISUAL ACUITY REDUCED 178 0.0054
378 VISUAL IMPAIRMENT 664 0.0054
379 INCORRECT PRODUCT ADMINISTRATION DURATION 116 0.0053
380 PRODUCT ADMINISTRATION INTERRUPTED 42 0.0053
381 SNEEZING 119 0.0053
382 RASH PRURITIC 285 0.0053
383 INJECTION SITE REACTION 361 0.0052
384 COLITIS 198 0.0052
385 IMPAIRED QUALITY OF LIFE 75 0.0052
386 SKIN WARM 30 0.0052
387 QUALITY OF LIFE DECREASED 69 0.0051
388 VULVOVAGINAL PRURITUS 26 0.0051
389 WOUND SECRETION 20 0.0051
390 EPISTAXIS 380 0.0051
391 EXPOSURE VIA BREAST MILK 20 0.0050
392 LIMB DISCOMFORT 155 0.0050
393 OCULAR DISCOMFORT 56 0.0050
394 SWELLING OF EYELID 31 0.0049
395 ASTHMA 555 0.0049
396 MULTIPLE ALLERGIES 38 0.0048
397 NIGHTMARE 166 0.0048
398 RASH MACULAR 167 0.0048
399 EAR DISCOMFORT 49 0.0048
400 DRUG EFFECT LESS THAN EXPECTED 70 0.0047
401 MUSCLE SPASMS 862 0.0047
402 APPLICATION SITE DISCOLOURATION 19 0.0047
403 ABDOMINAL PAIN UPPER 955 0.0046
404 ARTHRITIS BACTERIAL 19 0.0046
405 ANOSMIA 67 0.0046
406 OEDEMA PERIPHERAL 562 0.0046
407 SENSITIVE SKIN 34 0.0046
408 HAEMOGLOBIN INCREASED 21 0.0046
409 RESPIRATORY DISORDER 137 0.0046
410 UVEITIS 62 0.0046
411 SKIN DISCOLOURATION 210 0.0046
412 VITAMIN D DECREASED 39 0.0046
413 SINUS HEADACHE 27 0.0045
414 NEPHROGENIC ANAEMIA 21 0.0045
415 ADVERSE EVENT 415 0.0045
416 SNORING 17 0.0045
417 CONJUNCTIVAL HYPERAEMIA 16 0.0045
418 MEDICATION ERROR 249 0.0045
419 VITREOUS FLOATERS 44 0.0045
420 INSOMNIA 1186 0.0044
421 MUSCLE ATROPHY 56 0.0044
422 RHINORRHOEA 285 0.0044
423 EXPIRED PRODUCT ADMINISTERED 145 0.0044
424 ORAL HERPES 85 0.0044
425 STAPHYLOCOCCAL INFECTION 143 0.0043
426 SKIN ULCER 112 0.0043
427 NEPHROLITHIASIS 198 0.0043
428 PAROSMIA 32 0.0042
429 SKIN PAPILLOMA 17 0.0042
430 FOREIGN BODY SENSATION IN EYES 27 0.0042
431 INJECTION SITE INFLAMMATION 21 0.0042
432 PRODUCT QUALITY ISSUE 570 0.0042
433 SENSITIVITY TO WEATHER CHANGE 22 0.0042
434 FLUID RETENTION 212 0.0042
435 PRE-EXISTING CONDITION IMPROVED 26 0.0042
436 SCAR 71 0.0041
437 PYREXIA 1428 0.0041
438 JOINT INJURY 88 0.0041
439 DERMATITIS ACNEIFORM 25 0.0041
440 SKIN DISORDER 137 0.0041
441 VITAMIN D DEFICIENCY 40 0.0041
442 APPLICATION SITE PAIN 90 0.0041
443 DRUG INEFFECTIVE 5382 0.0041
444 HIDRADENITIS 37 0.0041
445 MUSCLE STRAIN 35 0.0040
446 HAIR GROWTH ABNORMAL 28 0.0040
447 DEPRESSION 903 0.0040
448 THERAPEUTIC PRODUCT EFFECT DELAYED 18 0.0039
449 LIGAMENT SPRAIN 39 0.0039
450 PAIN IN EXTREMITY 1161 0.0039
451 DRY THROAT 40 0.0039
452 ARTHRALGIA 1634 0.0039
453 SINUS CONGESTION 53 0.0039
454 INCREASED TENDENCY TO BRUISE 36 0.0039
455 EXPOSURE VIA SKIN CONTACT 101 0.0039
456 REBOUND EFFECT 44 0.0039
457 ERYTHEMA 789 0.0038
458 APPLICATION SITE SWELLING 19 0.0038
459 BRONCHITIS 282 0.0038
460 ASPERGILLUS INFECTION 25 0.0038
461 VOMITING 1782 0.0038
462 SKIN LACERATION 41 0.0038
463 RESPIRATORY TRACT INFECTION 98 0.0038
464 CATARACT 224 0.0038
465 DERMATITIS ALLERGIC 47 0.0037
466 SKIN HYPERPIGMENTATION 32 0.0037
467 GLUCOSE TOLERANCE IMPAIRED 22 0.0037
468 SKIN LESION 102 0.0037
469 PAIN 2283 0.0037
470 HAEMATOCHEZIA 205 0.0037
471 CHAPPED LIPS 16 0.0037
472 DECREASED APPETITE 855 0.0037
473 PLEURAL EFFUSION 223 0.0037
474 FURUNCLE 29 0.0037
475 SKIN INFECTION 41 0.0037
476 FEELING HOT 224 0.0037
477 EYE IRRITATION 210 0.0036
478 ECCHYMOSIS 25 0.0036
479 SPINAL OSTEOARTHRITIS 32 0.0036
480 HYPERVOLAEMIA 18 0.0036
481 CHEST PAIN 671 0.0036
482 PHARYNGITIS STREPTOCOCCAL 39 0.0036
483 RASH ERYTHEMATOUS 172 0.0036
484 FAECES SOFT 26 0.0036
485 WEIGHT DECREASED 980 0.0035
486 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 192 0.0035
487 SINUS DISORDER 69 0.0035
488 DRUG EFFECT INCOMPLETE 126 0.0035
489 VISUAL FIELD DEFECT 25 0.0035
490 OFF LABEL USE 3025 0.0035
491 CHOKING SENSATION 19 0.0034
492 LIVER FUNCTION TEST ABNORMAL 99 0.0034
493 DIZZINESS 1678 0.0034
494 APHTHOUS ULCER 26 0.0033
495 BREAST CANCER STAGE I 31 0.0033
496 MALAISE 1464 0.0033
497 EXTRA DOSE ADMINISTERED 134 0.0033
498 INJECTION SITE VESICLES 20 0.0033
499 PHOTOPHOBIA 62 0.0033
500 ORAL DISORDER 24 0.0033
501 ABDOMINAL PAIN 757 0.0033
502 PRODUCT DOSE OMISSION IN ERROR 92 0.0032
503 ARTHROPOD BITE 24 0.0032
504 STREPTOCOCCAL INFECTION 18 0.0032
505 URINE ODOUR ABNORMAL 19 0.0032
506 INITIAL INSOMNIA 33 0.0032
507 PRODUCT PREPARATION ISSUE 21 0.0032
508 FLANK PAIN 30 0.0032
509 EYE SWELLING 119 0.0032
510 ADVERSE DRUG REACTION 287 0.0032
511 DYSPNOEA EXERTIONAL 120 0.0032
512 ABDOMINAL DISTENSION 331 0.0032
513 BLINDNESS 129 0.0032
514 HEADACHE 1983 0.0032
515 WHITE BLOOD CELL COUNT INCREASED 121 0.0032
516 PNEUMONIA 1021 0.0032
517 LIQUID PRODUCT PHYSICAL ISSUE 23 0.0032
518 NERVE COMPRESSION 29 0.0031
519 ERYTHEMA MULTIFORME 29 0.0031
520 THERMAL BURN 22 0.0031
521 NECROSIS 17 0.0031
522 INFUSION SITE EXTRAVASATION 19 0.0030
523 CANDIDA INFECTION 51 0.0030
524 LABORATORY TEST ABNORMAL 89 0.0030
525 HYPERLIPIDAEMIA 36 0.0030
526 FUNGAL INFECTION 100 0.0030
527 OROPHARYNGEAL PAIN 277 0.0030
528 ORAL PAIN 67 0.0030
529 TACHYCARDIA 265 0.0030
530 ROTATOR CUFF SYNDROME 38 0.0030
531 INJECTION SITE SWELLING 226 0.0029
532 INSURANCE ISSUE 45 0.0029
533 SLEEP APNOEA SYNDROME 56 0.0029
534 DRUG SPECIFIC ANTIBODY PRESENT 19 0.0029
535 PRODUCT USE COMPLAINT 46 0.0029
536 PRODUCT DISTRIBUTION ISSUE 27 0.0029
537 ONYCHOCLASIS 20 0.0029
538 PAIN OF SKIN 78 0.0029
539 HEAD DISCOMFORT 51 0.0029
540 HYPERTRANSAMINASAEMIA 20 0.0029
541 INJECTION SITE RASH 88 0.0029
542 GAIT DISTURBANCE 548 0.0029
543 EYE DISORDER 94 0.0029
544 AGEUSIA 71 0.0028
545 FATIGUE 2216 0.0028
546 PRODUCT PACKAGING ISSUE 27 0.0028
547 INTENTIONAL DOSE OMISSION 81 0.0028
548 INJECTION SITE IRRITATION 36 0.0028
549 DIARRHOEA 1824 0.0028
550 BRONCHIECTASIS 19 0.0028
551 IRON DEFICIENCY ANAEMIA 26 0.0028
552 SUNBURN 21 0.0028
553 FACIAL PAIN 25 0.0028
554 PSEUDOMONAS INFECTION 24 0.0028
555 SECRETION DISCHARGE 35 0.0028
556 THROAT IRRITATION 125 0.0028
557 ILLNESS 287 0.0028
558 PHOTOSENSITIVITY REACTION 46 0.0028
559 ASTHENIA 1045 0.0028
560 SKIN REACTION 39 0.0028
561 PLATELET COUNT INCREASED 36 0.0028
562 RESPIRATORY SYNCYTIAL VIRUS INFECTION 24 0.0028
563 OPTIC NEURITIS 25 0.0027
564 TOOTH FRACTURE 30 0.0027
565 ARTERIOSCLEROSIS CORONARY ARTERY 18 0.0027
566 VISION BLURRED 373 0.0027
567 CATARACT OPERATION 16 0.0027
568 BODY TEMPERATURE INCREASED 55 0.0027
569 NAUSEA 2131 0.0027
570 PRODUCTIVE COUGH 128 0.0027
571 RESPIRATORY TRACT CONGESTION 42 0.0026
572 ANXIETY 748 0.0026
573 LIMB INJURY 71 0.0026
574 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 470 0.0026
575 INTERVERTEBRAL DISC DEGENERATION 24 0.0026
576 PRODUCT DOSE OMISSION ISSUE 759 0.0026
577 TOOTH INFECTION 34 0.0026
578 DIZZINESS POSTURAL 25 0.0026
579 PRODUCT ODOUR ABNORMAL 27 0.0026
580 BLINDNESS TRANSIENT 19 0.0026
581 SKIN IRRITATION 118 0.0026
582 ABSCESS 41 0.0026
583 BASAL CELL CARCINOMA 40 0.0026
584 HAEMORRHOIDS 50 0.0026
585 ASPIRATION 28 0.0026
586 BRAIN FOG 40 0.0025
587 PEMPHIGOID 19 0.0025
588 GINGIVAL PAIN 20 0.0025
589 TENDON RUPTURE 31 0.0025
590 ECONOMIC PROBLEM 38 0.0025
591 DYSPNOEA 1417 0.0025
592 CARPAL TUNNEL SYNDROME 35 0.0025
593 BOWEL MOVEMENT IRREGULARITY 19 0.0025
594 BLOOD PRESSURE INCREASED 378 0.0025
595 INJECTION SITE DISCOMFORT 26 0.0025
596 LOSS OF CONSCIOUSNESS 316 0.0025
597 PHARYNGEAL SWELLING 24 0.0025
598 BLOOD IRON DECREASED 29 0.0024
599 MUSCULOSKELETAL DISCOMFORT 42 0.0024
600 TOOTHACHE 44 0.0024
601 BURNING SENSATION 170 0.0024
602 TEMPERATURE INTOLERANCE 25 0.0024
603 CYST 30 0.0024
604 APPLICATION SITE IRRITATION 30 0.0024
605 INJECTION SITE PAIN 739 0.0024
606 SWELLING FACE 156 0.0024
607 DIVERTICULUM 17 0.0024
608 GROIN PAIN 21 0.0024
609 CONSTIPATION 521 0.0024
610 HYPERHIDROSIS 307 0.0024
611 FEAR OF INJECTION 17 0.0024
612 OSTEOPENIA 36 0.0024
613 FRUSTRATION TOLERANCE DECREASED 19 0.0023
614 VIRAL INFECTION 78 0.0023
615 ANAPHYLACTIC REACTION 129 0.0023
616 CELLULITIS 116 0.0023
617 INJECTION SITE URTICARIA 56 0.0023
618 LOCALISED INFECTION 55 0.0023
619 PRODUCT STORAGE ERROR 198 0.0023
620 COUGH 628 0.0022
621 PAIN IN JAW 63 0.0022
622 PRODUCT CONTAINER ISSUE 19 0.0022
623 FOOD ALLERGY 17 0.0022
624 ULCER 35 0.0022
625 LOW DENSITY LIPOPROTEIN INCREASED 17 0.0022
626 ATELECTASIS 21 0.0022
627 CLOSTRIDIUM DIFFICILE COLITIS 23 0.0022
628 FEELING JITTERY 41 0.0021
629 SQUAMOUS CELL CARCINOMA 20 0.0021
630 DYSPHONIA 124 0.0021
631 GOUT 38 0.0021
632 SENSORY LOSS 17 0.0021
633 RHINITIS 17 0.0021
634 NO ADVERSE EVENT 382 0.0021
635 INTERVERTEBRAL DISC PROTRUSION 46 0.0021
636 OROPHARYNGEAL DISCOMFORT 19 0.0021
637 PHARYNGITIS 26 0.0021
638 HEPATIC STEATOSIS 39 0.0021
639 RIB FRACTURE 43 0.0021
640 ORAL DISCOMFORT 29 0.0021
641 MASS 29 0.0021
642 HICCUPS 17 0.0021
643 ACCIDENTAL EXPOSURE TO PRODUCT 213 0.0021
644 HOSPITALISATION 317 0.0021
645 TOOTH ABSCESS 21 0.0021
646 PANCREATITIS 109 0.0021
647 NOCTURIA 25 0.0021
648 BLINDNESS UNILATERAL 29 0.0021
649 MENSTRUAL DISORDER 17 0.0021
650 EMBOLISM 17 0.0020
651 SKIN BURNING SENSATION 146 0.0020
652 HYPOTENSION 408 0.0020
653 THERAPEUTIC RESPONSE UNEXPECTED 91 0.0020
654 FALL 674 0.0020
655 HERPES ZOSTER 116 0.0020
656 DRUG INTERACTION 320 0.0020
657 PHARYNGEAL OEDEMA 31 0.0020
658 DIPLOPIA 52 0.0020
659 TENDONITIS 31 0.0020
660 INJECTION SITE MASS 74 0.0020
661 ANAL INCONTINENCE 18 0.0020
662 BACTERIAL INFECTION 37 0.0020
663 MADAROSIS 23 0.0020
664 END STAGE RENAL DISEASE 36 0.0020
665 IMMUNE SYSTEM DISORDER 26 0.0020
666 EYELID PTOSIS 20 0.0020
667 BLOOD POTASSIUM DECREASED 59 0.0020
668 COVID-19 342 0.0019
669 DECREASED ACTIVITY 21 0.0019
670 ANAEMIA 371 0.0019
671 POST PROCEDURAL COMPLICATION 37 0.0019
672 HOSPICE CARE 19 0.0019
673 THROAT TIGHTNESS 52 0.0019
674 PURPURA 17 0.0019
675 RASH PAPULAR 43 0.0019
676 PETECHIAE 20 0.0019
677 INTENTIONAL PRODUCT MISUSE 167 0.0019
678 SPINAL DISORDER 18 0.0019
679 FOOT FRACTURE 36 0.0019
680 GASTROINTESTINAL INFECTION 17 0.0019
681 HEAVY MENSTRUAL BLEEDING 17 0.0019
682 LEUKOCYTOSIS 34 0.0019
683 URINARY TRACT INFECTION 320 0.0019
684 PULMONARY HYPERTENSION 39 0.0019
685 SPINAL OPERATION 23 0.0019
686 BONE DISORDER 34 0.0019
687 BACK PAIN 433 0.0019
688 SLUGGISHNESS 19 0.0019
689 BLOOD PRESSURE SYSTOLIC INCREASED 36 0.0018
690 POOR VENOUS ACCESS 19 0.0018
691 WRIST FRACTURE 22 0.0018
692 KIDNEY INFECTION 36 0.0018
693 CHRONIC KIDNEY DISEASE 138 0.0018
694 RESTLESS LEGS SYNDROME 33 0.0018
695 NEUROPATHY PERIPHERAL 172 0.0018
696 APPLICATION SITE ERYTHEMA 47 0.0018
697 PRODUCT PRESCRIBING ISSUE 39 0.0018
698 HEART RATE INCREASED 177 0.0018
699 OSTEONECROSIS 58 0.0018
700 HYPOXIA 62 0.0018
701 ANHEDONIA 46 0.0017
702 INTERNAL HAEMORRHAGE 20 0.0017
703 INFLUENZA 195 0.0017
704 DISEASE RECURRENCE 83 0.0017
705 MUSCULOSKELETAL CHEST PAIN 27 0.0017
706 TINNITUS 80 0.0017
707 FLUSHING 176 0.0017
708 POLLAKIURIA 72 0.0017
709 PULMONARY ARTERIAL HYPERTENSION 25 0.0017
710 HYPOAESTHESIA ORAL 26 0.0017
711 HYPOACUSIS 74 0.0017
712 APPLICATION SITE PRURITUS 39 0.0017
713 INJECTION SITE PRURITUS 115 0.0017
714 FEELING ABNORMAL 410 0.0017
715 TOOTH DISORDER 38 0.0017
716 HIATUS HERNIA 22 0.0017
717 PRODUCT TASTE ABNORMAL 23 0.0017
718 INJECTION SITE INDURATION 22 0.0017
719 LYMPHADENOPATHY 60 0.0017
720 SURGERY 99 0.0017
721 URINARY INCONTINENCE 50 0.0017
722 CHROMATURIA 38 0.0017
723 BLOOD PRESSURE FLUCTUATION 40 0.0017
724 OXYGEN SATURATION DECREASED 93 0.0017
725 INJECTION SITE WARMTH 34 0.0017
726 NEURALGIA 40 0.0016
727 MALIGNANT MELANOMA 22 0.0016
728 HYPERSOMNIA 47 0.0016
729 VASCULITIS 19 0.0016
730 DYSURIA 60 0.0016
731 THROMBOCYTOPENIA 182 0.0016
732 GENERALISED OEDEMA 20 0.0016
733 HAEMOPTYSIS 45 0.0016
734 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 84 0.0016
735 BALANCE DISORDER 139 0.0016
736 HOT FLUSH 121 0.0016
737 RETCHING 34 0.0016
738 PULMONARY CONGESTION 21 0.0016
739 BLOOD SODIUM DECREASED 30 0.0016
740 HEREDITARY ANGIOEDEMA 17 0.0016
741 FLUID OVERLOAD 23 0.0016
742 RED BLOOD CELL COUNT DECREASED 45 0.0016
743 BONE PAIN 92 0.0016
744 MUSCLE TWITCHING 36 0.0016
745 UNEVALUABLE EVENT 117 0.0015
746 RASH GENERALISED 40 0.0015
747 INCORRECT ROUTE OF DRUG ADMINISTRATION 55 0.0015
748 CHEST DISCOMFORT 157 0.0015
749 SKIN CANCER 33 0.0015
750 LIP SWELLING 51 0.0015
751 NERVE INJURY 17 0.0015
752 CHOLELITHIASIS 50 0.0015
753 THIRST 27 0.0015
754 DEVICE FAILURE 23 0.0015
755 APHONIA 21 0.0015
756 PALPITATIONS 176 0.0015
757 MIDDLE INSOMNIA 28 0.0015
758 EYE HAEMORRHAGE 20 0.0015
759 THERAPY INTERRUPTED 107 0.0015
760 OSTEOMYELITIS 27 0.0015
761 FULL BLOOD COUNT DECREASED 30 0.0015
762 FLATULENCE 84 0.0015
763 MENORRHAGIA 29 0.0015
764 VERTIGO 90 0.0015
765 CYSTITIS 47 0.0015
766 MOOD SWINGS 47 0.0015
767 GLOMERULAR FILTRATION RATE DECREASED 18 0.0015
768 BLOOD PRESSURE ABNORMAL 29 0.0015
769 ACUTE RESPIRATORY FAILURE 28 0.0015
770 HAIR COLOUR CHANGES 18 0.0014
771 COMPLICATION ASSOCIATED WITH DEVICE 21 0.0014
772 TREATMENT NONCOMPLIANCE 79 0.0014
773 INJECTION SITE BRUISING 115 0.0014
774 INJECTION SITE ERYTHEMA 178 0.0014
775 PRURITUS GENERALISED 31 0.0014
776 GASTRIC DISORDER 49 0.0014
777 HEAD INJURY 45 0.0014
778 LEUKOPENIA 71 0.0014
779 PULMONARY MASS 21 0.0014
780 DRUG ADMINISTRATION ERROR 43 0.0014
781 DYSGEUSIA 104 0.0014
782 PRESYNCOPE 34 0.0014
783 THINKING ABNORMAL 26 0.0014
784 IMPAIRED GASTRIC EMPTYING 19 0.0014
785 POOR QUALITY SLEEP 30 0.0014
786 HYPERTHYROIDISM 20 0.0014
787 PANIC ATTACK 50 0.0014
788 PRODUCT PRESCRIBING ERROR 32 0.0013
789 INFLUENZA LIKE ILLNESS 110 0.0013
790 PRODUCT ADMINISTRATION ERROR 27 0.0013
791 DYSSTASIA 39 0.0013
792 MYALGIA 227 0.0013
793 GASTRITIS 35 0.0013
794 BLOOD COUNT ABNORMAL 20 0.0013
795 GINGIVAL BLEEDING 18 0.0013
796 CHILLS 153 0.0013
797 CARDIOMEGALY 16 0.0013
798 DRUG ERUPTION 23 0.0013
799 BEDRIDDEN 17 0.0013
800 ANKLE FRACTURE 20 0.0013
801 HYPOPHAGIA 33 0.0013
802 PRODUCT PHYSICAL ISSUE 26 0.0013
803 HAIR TEXTURE ABNORMAL 17 0.0013
804 EATING DISORDER 27 0.0013
805 FEELING COLD 35 0.0013
806 HAEMOGLOBIN DECREASED 129 0.0013
807 INCREASED APPETITE 24 0.0013
808 HEART RATE DECREASED 44 0.0013
809 LYMPHOCYTE COUNT DECREASED 22 0.0012
810 HYPOKINESIA 18 0.0012
811 RESPIRATORY DISTRESS 34 0.0012
812 PRODUCT AVAILABILITY ISSUE 28 0.0012
813 DIVERTICULITIS 34 0.0012
814 DRUG EFFECT DECREASED 66 0.0012
815 DEAFNESS 32 0.0012
816 HYPOMAGNESAEMIA 17 0.0012
817 PRODUCT PREPARATION ERROR 25 0.0012
818 SEPSIS 135 0.0012
819 GASTRIC ULCER 23 0.0012
820 BLOOD PRESSURE DECREASED 80 0.0012
821 PNEUMONIA ASPIRATION 30 0.0012
822 DEEP VEIN THROMBOSIS 78 0.0012
823 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 35 0.0012
824 MENSTRUATION IRREGULAR 32 0.0012
825 CLOSTRIDIUM DIFFICILE INFECTION 26 0.0012
826 NERVOUSNESS 62 0.0012
827 THROMBOSIS 95 0.0012
828 ACNE 89 0.0012
829 WHITE BLOOD CELL COUNT DECREASED 127 0.0012
830 ACCIDENTAL OVERDOSE 42 0.0011
831 INCORRECT DOSE ADMINISTERED 262 0.0011
832 IRRITABILITY 69 0.0011
833 DEHYDRATION 153 0.0011
834 BLOOD UREA INCREASED 19 0.0011
835 CRYING 41 0.0011
836 PLATELET COUNT DECREASED 120 0.0011
837 PERICARDIAL EFFUSION 26 0.0011
838 DISEASE PROGRESSION 133 0.0011
839 IMPAIRED WORK ABILITY 24 0.0011
840 SWOLLEN TONGUE 35 0.0011
841 SYNCOPE 112 0.0011
842 ATRIAL FIBRILLATION 109 0.0011
843 SOMNOLENCE 225 0.0011
844 DEPRESSED MOOD 59 0.0011
845 HAEMATOCRIT DECREASED 22 0.0011
846 GLYCOSYLATED HAEMOGLOBIN INCREASED 28 0.0011
847 BLOOD POTASSIUM INCREASED 18 0.0011
848 FAECES DISCOLOURED 24 0.0011
849 DYSPHAGIA 105 0.0011
850 BLOOD URINE PRESENT 21 0.0011
851 THYROID DISORDER 17 0.0011
852 PRODUCT DISPENSING ERROR 24 0.0011
853 NEEDLE ISSUE 32 0.0011
854 HYPOTHYROIDISM 35 0.0011
855 HALLUCINATION, VISUAL 23 0.0011
856 DIABETES MELLITUS 83 0.0011
857 PRODUCT DOSE OMISSION 71 0.0011
858 BLOOD ALKALINE PHOSPHATASE INCREASED 27 0.0011
859 FEEDING DISORDER 22 0.0011
860 HAEMATURIA 37 0.0011
861 RASH MACULO-PAPULAR 24 0.0011
862 UPPER LIMB FRACTURE 21 0.0011
863 ANAPHYLACTIC SHOCK 27 0.0010
864 BLOOD GLUCOSE INCREASED 197 0.0010
865 ERUCTATION 20 0.0010
866 DELUSION 16 0.0010
867 PANCREATITIS ACUTE 23 0.0010
868 URINARY RETENTION 34 0.0010
869 BLOOD TRIGLYCERIDES INCREASED 18 0.0010
870 RENAL FAILURE 134 0.0010
871 GALLBLADDER DISORDER 18 0.0010
872 GAMMA-GLUTAMYLTRANSFERASE INCREASED 22 0.0010
873 ABDOMINAL PAIN LOWER 25 0.0010
874 TREMOR 164 0.0010
875 HERNIA 19 0.0010
876 TRANSIENT ISCHAEMIC ATTACK 33 0.0010
877 DEVICE USE ISSUE 17 0.0010
878 PULMONARY EMBOLISM 92 0.0010
879 HAEMORRHAGE 101 0.0010
880 TOOTH LOSS 20 0.0010
881 LETHARGY 55 0.0010
882 INJECTION SITE HAEMORRHAGE 76 0.0010
883 OVERDOSE 205 0.0009
884 SPINAL FRACTURE 19 0.0009
885 SUICIDAL IDEATION 86 0.0009
886 HYPERGLYCAEMIA 34 0.0009
887 AGITATION 67 0.0009
888 STEVENS-JOHNSON SYNDROME 20 0.0009
889 MENTAL DISORDER 39 0.0009
890 ENCEPHALOPATHY 22 0.0009
891 PULMONARY OEDEMA 40 0.0009
892 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 30 0.0009
893 HYPONATRAEMIA 50 0.0009
894 HEART RATE IRREGULAR 20 0.0009
895 MULTIPLE ORGAN DYSFUNCTION SYNDROME 25 0.0009
896 MOVEMENT DISORDER 28 0.0009
897 HIP FRACTURE 28 0.0009
898 NEOPLASM MALIGNANT 58 0.0009
899 CORONARY ARTERY DISEASE 26 0.0009
900 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 20 0.0009
901 MOUTH ULCERATION 18 0.0009
902 HAEMATOMA 22 0.0008
903 FOETAL EXPOSURE DURING PREGNANCY 69 0.0008
904 ASPARTATE AMINOTRANSFERASE INCREASED 45 0.0008
905 PLASMA CELL MYELOMA 33 0.0008
906 RESPIRATORY FAILURE 61 0.0008
907 ACUTE KIDNEY INJURY 127 0.0008
908 HALLUCINATION 62 0.0008
909 DISTURBANCE IN ATTENTION 44 0.0008
910 INTERNATIONAL NORMALISED RATIO INCREASED 23 0.0008
911 SPEECH DISORDER 42 0.0008
912 NERVOUS SYSTEM DISORDER 25 0.0008
913 CARDIAC FAILURE CONGESTIVE 64 0.0008
914 ABNORMAL DREAMS 22 0.0008
915 SEIZURE 92 0.0008
916 RENAL DISORDER 37 0.0008
917 MENTAL STATUS CHANGES 22 0.0008
918 ALANINE AMINOTRANSFERASE INCREASED 48 0.0008
919 CARDIAC DISORDER 73 0.0008
920 DRUG RESISTANCE 20 0.0008
921 BLOOD GLUCOSE DECREASED 37 0.0008
922 MOOD ALTERED 21 0.0008
923 INTESTINAL OBSTRUCTION 29 0.0008
924 ANGER 26 0.0008
925 DEVICE DISLOCATION 33 0.0008
926 ASCITES 22 0.0007
927 FEAR 20 0.0007
928 RENAL INJURY 22 0.0007
929 WITHDRAWAL SYNDROME 31 0.0007
930 DYSKINESIA 30 0.0007
931 VAGINAL HAEMORRHAGE 32 0.0007
932 PNEUMONITIS 20 0.0007
933 ANGIOEDEMA 32 0.0007
934 DEVICE ISSUE 64 0.0007
935 EMOTIONAL DISORDER 22 0.0007
936 EMOTIONAL DISTRESS 86 0.0007
937 COGNITIVE DISORDER 33 0.0007
938 BLOOD CREATININE INCREASED 46 0.0007
939 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 141 0.0007
940 DEATH 598 0.0007
941 DEMENTIA 19 0.0007
942 RENAL IMPAIRMENT 57 0.0007
943 DEVICE MALFUNCTION 47 0.0007
944 CEREBROVASCULAR ACCIDENT 113 0.0007
945 DYSARTHRIA 25 0.0007
946 ERECTILE DYSFUNCTION 17 0.0007
947 UNRESPONSIVE TO STIMULI 17 0.0007
948 DISORIENTATION 26 0.0007
949 RESTLESSNESS 24 0.0007
950 CEREBRAL INFARCTION 16 0.0007
951 NEOPLASM PROGRESSION 22 0.0006
952 APHASIA 19 0.0006
953 ANGINA PECTORIS 18 0.0006
954 PSYCHOTIC DISORDER 18 0.0006
955 BRADYCARDIA 32 0.0006
956 FEBRILE NEUTROPENIA 40 0.0006
957 HYPERKALAEMIA 21 0.0006
958 ACUTE MYOCARDIAL INFARCTION 17 0.0006
959 MULTIPLE SCLEROSIS 27 0.0006
960 GASTROINTESTINAL HAEMORRHAGE 47 0.0006
961 CARDIAC FAILURE 45 0.0006
962 ARRHYTHMIA 26 0.0005
963 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 39 0.0005
964 RENAL FAILURE ACUTE 23 0.0005
965 MULTIPLE SCLEROSIS RELAPSE 37 0.0005
966 NEUTROPHIL COUNT DECREASED 22 0.0005
967 PANCYTOPENIA 30 0.0005
968 INTERSTITIAL LUNG DISEASE 25 0.0005
969 DRUG DOSE OMISSION 81 0.0005
970 LUNG NEOPLASM MALIGNANT 20 0.0005
971 DEVICE LEAKAGE 21 0.0005
972 ABNORMAL BEHAVIOUR 19 0.0005
973 MALIGNANT NEOPLASM PROGRESSION 49 0.0005
974 NEUTROPENIA 65 0.0005
975 HYPOGLYCAEMIA 23 0.0005
976 CEREBRAL HAEMORRHAGE 16 0.0004
977 AGGRESSION 22 0.0004
978 DEVICE BREAKAGE 17 0.0004
979 THERAPY CESSATION 21 0.0004
980 RHABDOMYOLYSIS 17 0.0004
981 MYOCARDIAL INFARCTION 65 0.0004
982 DEVICE DIFFICULT TO USE 23 0.0003
983 SUICIDE ATTEMPT 21 0.0003
984 BREAST CANCER 30 0.0003
985 PRODUCT SUBSTITUTION ISSUE 18 0.0003
986 CONVULSION 17 0.0003
987 DRUG WITHDRAWAL SYNDROME 25 0.0003
988 DRUG DEPENDENCE 40 0.0002
989 CARDIAC ARREST 18 0.0002
990 PROSTATE CANCER 17 0.0002